person
as of 2026-07-01Julie Adams
at a glance
Roles: Study Director, Author
KOL signal score 11
4 publications · 3 high-value
Cross-drug reach: 1 competitor drugs
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
AbbVie
Roles
Study Director, Author
KOL signal
11
Publications
4 (3 high-value)
Trial investigator
no
Publishes on
1 drugs
Trials led
1
A Trial of 15 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia
NCT05227703Phase 2Completed
Publications & congress
4
The effect of adjunctive cariprazine on symptoms of anhedonia in patients with major depressive disorder.
Journal of affective disorders · 2025 · high-value
Efficacy of Adjunctive Cariprazine on Anxiety Symptoms in Patients With Major Depressive Disorder: Post Hoc Analysis of a Randomized Placebo-Controlled Trial.
The Journal of clinical psychiatry · 2025 · high-value
Cariprazine as a maintenance therapy in the prevention of mood episodes in adults with bipolar I disorder.
Bipolar disorders · 2024 · high-value
Efficacy and Clinical Relevance of Adjunctive Cariprazine Treatment in Patients with Major Depressive Disorder: Post Hoc Analyses from a Phase III Study.
Neuropsychiatric disease and treatment · 2026
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
publishes on